Focus Partners Wealth
DGX icon

Focus Partners Wealth’s Quest Diagnostics DGX Stock Holding History

Focus Partners Wealth’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.6M Sell
150,856
-3,126
-2% -$607K 0.03% 403
2025
Q4 		$26.7M Buy
153,982
+12,625
+9% +$2.3M 0.03% 422
2025
Q3 		$26.9M Buy
141,357
+87,300
+161% +$15.5M 0.04% 335
2025
Q2 		$9.71M Sell
54,057
-1,550
-3% -$269K 0.02% 504
2025
Q1 		$9.41M Buy
55,607
+5,123
+10% +$842K 0.02% 488
2024
Q4 		$7.62M Buy
50,484
+14,266
+39% +$2.22M 0.02% 521
2024
Q3 		$5.62M Buy
36,218
+30,469
+530% +$4.55M 0.02% 533
2024
Q2 		$787K Buy
5,749
+67
+1% +$9.18K ﹤0.01% 849
2024
Q1 		$756K Buy
+5,682
New +$737K 0.01% 651

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Focus Partners Wealth's DGX Position: Q1 2026 in Review

Focus Partners Wealth reduced its Quest Diagnostics (DGX) stake by 2% in Q1 2026, selling an estimated $607K and leaving 150,856 shares worth $29.6M. The position accounts for 0.03% of the portfolio, ranked #403.

Focus Partners Wealth first reported a position in DGX in Q1 2024 and has held it in 9 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Focus Partners Wealth held 150,856 shares of Quest Diagnostics worth $29.6M as of Q1 2026.
  • Focus Partners Wealth sold 3,126 Quest Diagnostics shares in Q1 2026, an estimated $607K.
  • Quest Diagnostics made up 0.03% of Focus Partners Wealth's portfolio in Q1 2026, its #403 holding.
  • Focus Partners Wealth first reported a position in Quest Diagnostics in Q1 2024 and has held it in 9 quarters since.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.